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Objectives: To identify and synthesize the evidence for the use and measurement properties of musculoskele-
tal ultrasound in assessing structural joint damage in patients with rheumatoid arthritis (RA).
Methods: A systematic literature search (SLR) of the PubMed, Embase and Cochrane Library was performed.
Original articles were included published in English reporting on ultrasound of bone erosion, cartilage dam-
age and the measurement properties of ultrasound according to the OMERACT filter 2.1.
Results: Of the 1.495 identified articles 149 were included in the final review, most of which reported on
cross-sectional studies and used the OMERACT definitions for ultrasonographic pathology. Among these,
bone erosions were assessed in 139 (93.3%), cartilage damage in 24 (16.1%), enthesophytes in 8 (5.4%), osteo-
phytes in 15 (10.1%) and malalignment and ankylosis in a single (0.9%) study, respectively. Most studies
(126/149, 84.6%) assessed the joints of the hands. The overwhelming majority of studies (127/149, 85.2%)
assessed structural joint damage bilaterally. Validity, reliability and responsiveness were assessed in 21
(14.1%), 34 (22.8%) and 17 (11.4%) studies, respectively.
Conclusion: While the results of this SLR suggest that ultrasound is a sensitive, reliable and feasible tool to
detect damage in RA, they also highlight the need for further research and validation. Findings of this SLR
will inform the next steps of the OMERACT Ultrasound Working Group in developing an ultrasound score for
assessing structural joint damage in patients with RA.








c. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)Introduction
Early diagnosis is the key to a successful therapy in rheumatoid
arthritis (RA) and to prevent the progression of structural damage in
synovial joints [1]. Joint damage in RA includes, among others loss of
hyaline cartilage [2] and bone erosions [3]. The detection of these
two components is crucial not only for diagnosis but also for monitor-
ing of therapeutic targets [4]. Malalignment can also be observed inRA, which however is less commonly used as an outcome parameter
[5,6]. The occurrence of osteophytes is mainly regarded as a sign of
secondary osteoarthritis [7,8] while some suggest a more direct asso-
ciation with RA disease [9].
Conventional radiography (CR) is the most commonly used
imaging technique to identify patients with structural joint dam-
age in daily clinical practice and research. Radiographic scores to
quantify damage assessed are published, validated and broadly
used, particularly in clinical trials [10,11]. Over the last two deca-
des, several other imaging techniques like musculoskeletal ultra-
sound, magnetic resonance imaging (MRI) and computed
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alternatives to detect both cartilage damage [2,12] and bone ero-
sions [3,13].
Musculoskeletal ultrasound has several advantages over MRI, CT
and CR. Ultrasound is easily and immediately available, relatively
cheap, not associated with radiation, and can be applied to almost all
synovial joints within the framework of a single examination and to
all patients. Joints can be additionally examined for the presence of
erosions, cartilage loss but also synovitis and in addition to articular
structures, the involvement of periarticular tissues such as tendon
damage, tenosynovitis or enthesitis.
Several sonographic scoring systems for erosions and/ or cartilage
damage have been proposed over the last few decades, none of which
are utilized widely [1418]. A semiquantitative scoring system for carti-
lage damage detected by ultrasoundwas developed recently by the Out-
come Measures in Rheumatology (OMERACT) Ultrasound Working
Group and was shown to be reliable in the assessment of hyaline carti-
lage of the metacarpal head [2].
We therefore aimed to systematically review current evidence for
the use of ultrasound in detecting structural joint damage in patients
with RA. We furthermore aimed to gain an understanding of the defi-
nitions and scoring systems which are reported in published litera-
ture and to evaluate their metric properties according to the
OMERACT filter 2.1, including recommendations for target joints.
Methods
Search strategy
Members of the Structural Joint Damage Task Force of the OMER-
ACT Ultrasound WG used the “Population, Intervention, Control and
Outcome” (PICO) system to develop the search strategy (Supplemen-
tary File) [19]. Subsequently, a systematic literature search with the
key words rheumatoid arthritis, ultrasound, bones/cartilage/joints
and damage (for exact search terms see Supplementary File) was per-
formed in the Embase, Medline and Cochrane Central Register of Con-
trolled Trials databases. Original articles published until October 2020
and abstracts presented at the European League Against Rheumatism
(EULAR) and American College of Rheumatology (ACR) annual scien-
tific meetings from January 2018 to October 2020 assessing joint
damage in RA by ultrasound were screened. To ensure not missing
any suitable articles, an additional hand search was performed in
Scopus. Titles, abstracts and full reports of articles were screened for
inclusion and exclusion criteria. We included a) original articles or
abstracts presented at EULAR or ACR scientific meeting; b) written in
English; c) in which the study population included adult (18 years)
patients with RA or suspected RA and which d) assessed damage by
ultrasound. Studies were excluded if they featured less than 20
included patients with RA/suspected RA.
Data extraction
We used a standardized template adapted from previous system-
atic literature reviews (SLRs) performed by the OMERACT Ultrasound
WG [20]. Data from selected articles regarding study population,
imaging techniques, number of included patients, joints and lesions
assessed, scoring system and main findings regarding the study ques-
tion were extracted.
Assessment of quality
A quality assessment tool for diagnostic accuracy studies (QUA-
DAS-2) was applied for all included studies to quantify quality [21]. It
consists of four key domains: patient selection, index test, reference
standard and flow and timing. Risk of bias and concerns regardingapplicability (only for the first three domains) were assessed for each
domain for every study.
Results
The primary search identified 1.484 articles. Eleven additional
articles were found through other sources. After fulfilling inclusion
and exclusion criteria and excluding duplicates, 149 studies remained
and were included in the review (Fig. 1).
Technical parameters
All studies assessed structural joint damage in gray scale. The
overwhelming studies utilized high frequency, linear transducers
(range 5-22 MHz). No frequency was provided in 36/149 (24.2%)
studies. Other parameters for gray scale such as gain, dynamic range,
number of foci, were not standardized or provided in the studies.
Two studies [12] focusing on cartilage damage utilized stringent
methodology corresponding to a critical review which suggested
ensuring an insonation angle of 90 degrees and including the carti-
lage interface sign when measuring cartilage thickness [22].
Assessed sites
The majority of the included studies assessed any joints of the
hands (wrists, metacarpophalangeal, proximal interphalangeal or
distal interphalangeal joints) and/or metatarsophalangeal joints
(MTPs) (111/149, 74.5%). In 36/149 (24.2%) studies, other joints
including the shoulders, knees, hips, sternoclavicular and temporo-
mandibular joints were examined. Fifteen out of 149 studies (10.1%)
assessed any joints of the hands and MTPs as well as other joints. All,
but 22/149 (14.8%) studies assessed joints bilaterally: 12/149 (8.1%)
studies [2332] scored the clinically more affected side only. The
dominant hand and the right hand were assessed in 8/149 (5.4%)
[3340] and 1/149 (0.7% ) [41] studies, respectively. One study did
not provide information regarding the assessed side [42] (Table 1).
Assessed lesions
Bone erosions
In total, 139/149 (93.3%) included studies assessed erosions in RA
patients. Among these, 107/139 (77%) studies used a binary grading
(presence/ absence per patient or per joint) method. In 18/139
(12.9%) studies [16,17,25,28,30,32,34,36,41,4351], a global erosion
score was provided, calculated either as the sum of joints with at
least one erosion or as the sum of joint quadrants with at least one
erosion. In 44/139 (31.7%) studies, a semiquantitative score was cal-
culated including the number and/or size of erosions. Four studies
assessed erosions quantitatively by measuring the longitudinal diam-
eter or the size of the erosions inmm [52] and/ or qualitatively
(shape, well-defined border, location, presence of overhanging mar-
gin)(45, 53) (Table 1).
In the majority of studies (47/139, 33.8%) erosions were assessed
according to the OMERACT definition [54] published by Wakefield
et al. in 2005: “intraarticular discontinuity of the bone surface that is
visible in 2 perpendicular planes”. A similar definition published by
Szkudlarek et al. in 2003 [55] was used in 13/139 (9.4%) included
studies with “cortical break seen in two perpendicular planes”. No
definition at all was provided in 46/139 (33.1%) studies. Four studies
(2.9%) included size in the definition of a definitive erosion: > 1mm
in 2 studies [56,57], <2mm in one study [58] and >2 mm in another
study [43].
In 105/139 (75.5%) studies, any joints of the hand or the MTPs
were assessed for erosions. In 27/139 (19.4%) studies, other joints
including shoulder, knee, elbow, talonavicular joint, subtalar joint,
hip, sternoclavicular joint and temporomandibular joint were
Fig. 1. Flowchart of study selection.
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well as other joints were assessed (Table 1).
Criterion validity assessed as comparison with other imaging
methods was investigated in only 20/139 (14.4%) studies
[14,23,30,37,39,50,52,5970], while 27/120 (22.6%) of the remaining
studies listed the frequency of detected erosions by ultrasound com-
pared to MRI or CR. Validity was good to excellent (intraclass correla-
tion coefficient (ICC) 0.61, kappa (K)  0.61, agreement  61% or
Kendall’s W  0.61) in 6/14 (42.9%) studies using a binary rating
(range: sensitivity: 27-100%, correlation coefficient R (R): 0.3-0.7, K:
0.5-0.9) while 2 studies did not state the exact results. Among studies
using semiquantitative scoring, validity was good to excellent in 3/4
(75%) studies (range: agreement: 65-93%, R: 0.3-0.7, Pearson’s
r=0.68). Inter- or intrarater reliability was assessed in 25/104 (24%)
studies. Good to excellent agreement was found in 20/25 studies
reporting reliability (80%). Reliability was good to excellent in 14/
16 (87.5%) studies using a binary scoring (range: ICC: 0.93-0.99,
K: 0.4-0.89, agreement: 88-98%, Kendall’s W: 0.85, Pearson’s cor-
relation coefficient: 0.9, Gwet’s AC1: 0.80), in 10/13 (76.9%) stud-
ies using semiquantitative scoring (range: ICC: 0.2-0.97, K: 0.5-1,
agreement: 85-98%, R: 0.5-0.8), in 0/2 (0%) studies using a quanti-
tative scoring (range: concordance correlation coefficient:0.5-1,
ICC:0.1-0.4) and in 1/1 (100%) study using a qualitative scoring
(K=0.8). Progression of erosions, defined as an increase in the
number of erosions or semiquantitative score, was assessed in
16/139 (11.5%) studies [25,32,34,35,37,41,43,60,7178], 9 (56.3%)
of which showed a significant difference over time
[35,37,41,43,7274,76,78]. Sensitivity to change was found in 6/
13 (46.2%) studies using a binary rating and in 3/4 (75%) using a
semiquantitative rating. Feasibility was assessed in only two stud-
ies [53,79] in which ultrasound was shown to be feasible when
scanning for bone erosions was restricted to few target areas
(Table 2).Enthesophytes and osteophytes
Eight out of 149 (5.4%) studies assessed enthesophytes in RA
patients [65,69,8085]. Results were reported as binary (present/
absent). Enthesophytes were assessed according to the OMERACT
definition published by Terslev et al. [86] in one study. In two studies
(25%) [69,85], enthesophytes were defined as “step-up of bony prom-
inence, seen in two perpendicular planes at the end of the bone
contour of the enthesis”. Interobserver agreement was reported
as good (K=0.68) in a single study, while criterion validity was
rated as excellent (ultrasound vs. CR; K=0.86) in an additional
study [65,83]. A single study assessed insertions of the 2nd to 4th
flexor tendons of the hand, while the other studies examined
entheses of other joints/sites including the knee, heel, shoulder
and midfoot joints (Tables 1 and 2).
Osteophytes were assessed in 15/149 (10.1%) studies
[56,57,69,80,85,8796] all of which used binary grading. One study
[93] additionally assessed osteophytes quantitatively by measuring
the longitudinal length. Osteophytes were defined as bony promi-
nence or enlargement in 6/15 (40%) studies [56,57,69,85,89,91] and
as irregularity of the bone contour in one study (10%) [87] while no
definition was given in the remaining 8/15 (53.3%) studies. Three
studies found good to excellent interobserver reliability of osteo-
phytes (K=0.64-0.88) [89]. Seven out of 15 (46.7%) studies assessed
the joints of the hand. Other studies assessed the sternoclavicular
joint, the hip, the knee, the ankle and the shoulder (Tables 1 and 2).
Cartilage damage
Among the 149 included studies, cartilage damage was assessed
in 24 (16.1%) studies. Four out of the 24 included studies (16.7%)
assessing cartilage used the semiquantitative score proposed by Dis-
ler et al. [77,9799]. In the remaining studies, cartilage damage
(binary/semiquantitative) was defined by partial or full thickness
defects of the cartilage layer in 7/24 (29.2%) studies
Table 1
Overview of included studies.
Ref. Population Technique No. patients Joints assessed Scoring system(s) Lesions
assessed
[59] RA/HC CR/US/MRI 65 Shoulder B BE
[34] RA/PsA US/CR 120 MCP2,3/PIP2,3/MTP2,5 B/ESS BE
[43] RA US/CR 21 MCP2,5/MTP5/most swollen PIP B/ESS BE
[60] RA US/MR/CR/CT 49 Wrist/MCP15 B BE
[61] RA US/CT 49 MCP2-5 B/S BE
[117] Susp. RA US/CR 58 $ B BE
[118] RA US 20 PIP2/MCP2-3/MTP5 B/S BE
[35] EA CR/US/MRI 70 Distal ulna S BE
[119] RA US 48 MTP5 B BE
[71] RA US/CR 82 Elbow/wrist/MCP2-3/ knee/ankle B BE
[17] RA US/CR 24 MCP1-5 B/ESS BE
[23] RA US/CR 38 Wrist/MCP1-5/PIP1-5/MTP 2-5 S BE
[72] RA US 40 1 PIP/1 MCP S BE
[62] RA US/MRI 30 MCP2-5/PIP2-5 B BE
[66] RA US 30 MCP2-3/PIP2/MTP1-2 S BE
[63] RA/HC US/MR/CR 60 MCP2-5/PIP2-5 B BE
[18] RA/HC US/MRI/CR 60 MTP1-5 B/S BE
[33] RA US/CR/MRI 100 MCP1-5 B/S/Q BE
[120] RA/PsA/Go/OA/HC US 310 Distal radius and ulna/MCP2- 3,5/PIP 2-3/MTP1+5 B/S BE
[73] EA US 63 Wrist/MCP2+5/MTP5 B/S BE
[64] RA US/MRI 50 Wrist/MCP2-5 B BE
[74] EA US/CR 79 Hand and feet B BE
[41] RA US/CR/MRI 46 Wrist/MCP1-5/PIP1-5 B/ESS BE
[24] RA US/CR/MRI 26 MCP1-5/MTP1-5 B BE
[45] RA/Go US/CR 80 MTP1-5 B/ESS/Ql/Q BE
[75] RA, US 274 MCP2-3+5/MTP5 B BE
[50] RA US/CR 122 MCP2-3+5/MTP2-3+5 S/ESS BE
[16] RA US 77 MCP1-5/PIP1-5/MTP1-5 S/ESS BE
[37] RA/AS/CTD/UA US/CR/MRI/SZ 49 MCP1-5/PIP1-5/DIP1-5 B BE
[121] RA US 32 MTP2+5 B BE
[25] RA 3DUS 26 MCP2+5/MTP1+5 B/ESS BE
[76] RA 2D/3DUS 85 MCP1-5 B BE
[39] ERA 3DUS/CT/CR 20 Wrist/MCP2-5/PIP2-5 B BE
[30] RA US/MRI 31 Wrist/MCP2-4/PIP2-4 B/ESS BE
[52] RA 3DUS/MRI 28 MCP2-3 B/S/Q BE
[32] RA/PsA/AS US 45 Wrist/MCP2-3/PIP2-3/MTP2+5 B/ESS BE
[67] RA/HC US/HR-pQCT 81 MCP1-5/PIP1-5 B/Q BE
[68] RA US/CR 108 MCP2-3+5/MTP2-3+5 S BE
[122] RA US/CR 108 MCP2-3+5/MTP2-3+5 B/S BE
[78] RA US/CR 60 WRIST/MCP1-5 B BE
[70] ERA US/MRI 39 MTP2-5 B BE
[83] RA/PsA/HC US 94 Flexor tendons B EP
[89] RA/HC US 206 STCJ B BE, OP
[65] RA/PsA/OA US/CR 598 Heel B BE, EP
[69] RA US/MRI 35 Heel, ankle B BE, OP, EP
[85] RA/HC US 70 Heel, ankle B BE, OP, EP
[12] RA/HC/cadaveric
specimen
US/CR 47 MCP Q/summary score CTh
[104] RA US 20 MCP2+3 B, S CD
[27] RA US/MRI 30 Knee B,/Q CD, CTh
[111] RA US 60 Wrist/MCP2-3/PIP2-3 B,/S BE, CD
[14] RA US/CR 125 Elbow S BE, CD




[105] RA/HC US 39 Wrist/MCP1-5 S BE, CD
[101] ERA US/CR 48 Wrist/MCP2-3/PIP2-3 B,/S BE, CD
[77] RA US/CR 132 MCP1-5 S BE, CD
[99] RA/OA US 86 MCP2-5 B,/S CD
[103] RA/HC US/CR 145 MCP2-5/PIP2-5 S,/Q CD
[46] RA 2D/3DUS 31 Wrist/MCP2-3/PIP2-3/MTP2,5 B/ESS BE
[123] ERA/RA/H/RMD US/CR 198 Wrist/MCP1-5/PIP1-5/DIP1-5 B BE
[124] ERA US 34 Wrist/MCP2-5/PIP1-5 S BE
[125] RA US 60 Wrist/MCP 1-5/PIP 1-5 B BE
[126] RA US/CEUS 39 Wrist/MCP1-5/PIP1-5/elbow/knee S BE
[127] RA US 41 Wrists/MCP 1-5/PIP1-5 B BE
[128] RA/HC US 83 Ankle B BE
[129] EA CR/US 126 MCP2+5/MTP5 B/S BE
[130] RA CR/US/MRI 43 Shoulder S BE
[131] RA US 25 Wrist/MCP2+5/PIP3/knee S BE
[132] RA US 30 MCP1-5/PIP1-5 B BE
[133] RA/HC US 138 # B/S BE
[134] RA/HC US 89 Shoulder B BE
(continued)
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Table 1 (Continued)
Ref. Population Technique No. patients Joints assessed Scoring system(s) Lesions
assessed
[135] RA US 24 MCP2-5 B/S/Q BE
[136] RA US/CR 47 Wrist/MCP1-5/PIP 2-5 B BE
[137] EA US/MRI 62 Wrist/MCP1-5/PIP1-5 S BE
[138] RA US 22 MCP2-3/PIP2-3/MTP2-5 B BE
[139] EA/HC US 84 Wrists/MCP 2-5 B BE
[47] EA US/CR 40 MCP1-5 B/ESS BE
[140] EA US 174 Hand and finger joints/MTP1-5 B BE
[36] RA US 30 Wrist/MCP2-3/PIP2-3/MTP2+5 ESS BE
[141] EA US 40 MCP2+5 B BE
[142] RA US 51 @ B BE
[143] EA CR/US 30 MTP5 B/S BE
[144] RA US/CR 122 MCP2-3+5/MTP2-3+5 S BE
[53] ERA/RA US 110 MCP2+5/ulnar head/MTP1+5 B/Q BE
[145] IA US/CR 144 Wrist/MCP 2-5/MTP5/most swollen PIP B BE
[38] IA US/MRI 32 Wrist/MCP1-5 B BE
[28] RA US 432 Wrist/MCP2-3/PIP2-3/MTP2+5 B/ESS BE
[146] RA US/CR/MRI/CT 26 shoulder B/S BE
[29] RA US 20 Wrist/MCP2+3/PIP 2+3/MTP2+5 B BE
[147] RA US 40 Wrist/MCP1-5/PIP1-5 B BE
[148] Susp RA US/CR 94 Wrist/MCP1-5/PIP1-5 B BE
[149] ERA US/MRI 39 Wrist/MCP1-5/PIP1-5 B BE
[150] RA US/CR 288 Wrist/MCP1-5/PIP1-5/elbow/shoulder/knee B BE
[31] RA/AS/HC US 114 Shoulder B BE
[151] RA US/MRI 30 Wrist/MCP2-4 B BE
[152] RA/OA/HC US 156 MTP1-5 B BE
[48] RA US/CR 30 MTP1-5/ tibiotalar joint, subtalar joint, talonavicular joint B/ESS BE
[49] EA US/MRI/CR 30 Wrist/MCP2-5 S/ESS BE
[40] RA US 20 Wrist/MCP2-5/PIP2-5/MTP2-5 B/S BE
[44] EA US/CR 127 MCP2+5/MTP5 B/ESS/S BE
[153] RA US/CR 40 n/a B BE
[154] RA/HC US 120 Sternoclavucular joint B BE
[155] RA/RMD US 101 Wrist /MCP1-5/PIP1-5/MTP1-5 B BE
[156] RA US 90 10 hand joints B BE
[157] RA/HC US 180 Wrist /MCP2-3/PIP2-3 B BE
[158] UA US 204 Wrist /MCP2-3/PIP2-3/MTP2+5 B BE
[159] RA US 50 Wrist/MCP2-5/PIP2-5 B BE
[160] RA/HC US 80 Wrist/MCP2-3/PIP2-3/MTP2+5 B/S BE
[161] RA US 62 Wrist/MCP2-3/PIP 2-3/MTP2+5 B BE
[162] RA US 86 Wrist B BE
[163] RA US/CR 50 Wrist/MCP1-5/PIP1-5 S BE
[79] RA US 30 Elbow/Wrist/MCP1-5/PIP1-5, ankle, MTP1-5 B BE
[164] RA US 30 n/a B BE
[51] RA US 30 Elbow/Wrist/MCP1-5/PIP1-5, ankle, MTP1-5 B,/ESS BE
[165] RA US 30 Elbow/Wrist/MCP1-5/PIP1-5, ankle, MTP1-5 B BE
[166] RA US 30 Elbow/Wrist/MCP1-5/PIP1-5, ankle, MTP1-5 B BE
[42] RA US 62 n/a B BE
[167] RA/ACPA HC US/CR 82 Joints of the hand and feet B BE
[168] RA US, MRI 80 MCP2-5/PIP2-5 B BE
[169] ACPA HC/ ACPA arthritis US 400 MCP2+5/MTP5 B/ S BE
[170] RA US 30 Elbow/Wrist/MCP1-5/PIP1-5, ankle, MTP1-5 B BE
[171] ACPA HC/ ACPA arthritis US 64 Wrist/MCP1-5/ PIP1-5/DIP1-5/Joints of the feet B BE
[172] RA US 30 Wrist/MCP1-5/PIP1-5/MTP1-5/elbow/ankle B BE
[88] ERA US 98 22 joints of the hand B BE, OP
[82] RA/AS/HC US 62 * B BE, EP
[84] RA/PsA US 80 Knee B BE, EP
[57] RA/OA/HC US 50 MCP1-5/PIP1-5 B BE, OP
[90] RA US 37 Shoulder B/S BE, OP
[80] RA US 100 Shoulder B BE, EP, OP
[56] RA/OA/HC US 52 MCP1-5/PIP1-5 B/S BE, OP
[81] RA US 100 MTP1-5/PIP1-5/midfoot joints B BE, EP
[91] RA US 46 Wrist/MCP1-5/PIP1-5 B BE, OP
[92] RA US 224 Wrist/MCP1-5/PIP1-5 B BE, OP
[94] RA/HC US 44 SCJ/manubriosternal joint B BE, OP, ankylosis
[95] RA US 43 Wrist/MCP1-5/PIP1-5/elbow/shoulder/knee B BE, OP
[96] RA/OA/HC US 120 Wrist/MCP1-5/PIP1-5/DIP1-5 B BE, OP
[108] RA, HC US 80 Knee Q CTh
[107] RA/OA/HC US 138 Knee B,/Q CD, CTh
[109] RA US 100 Knee B CD, BE
[26] RA/DSD US 178 Shoulder B BE, CD
[106] RA US 20 MCP1-5/ hand tendons B BE, CD
[100] RA US/MRI 50 Wrist/MCP2-5 S BE, CD
[93] RA/OA US 42 Knee B BE, CTh, OP
[87] RA US 52 Hip B BE, CD, OP
[110] RA US 61 Knee Q CTh
(continued)
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Table 1 (Continued)
Ref. Population Technique No. patients Joints assessed Scoring system(s) Lesions
assessed
[112] RA US 60 Wrist/MCP1-5 S BE, CD
[116] RA US/CR/MRI 20 TMJ B/S BE, DDP
[113] RA US 100 Wrist/MCP1-5/PIP1-5 B,/S BE, CD
[102] RA/HC US 40 MCP2-5 S/Q CD, CTh
[114] RA US 53 Wrist/MCP1-5/PIP1-5 B BE, CD
$MCP1-5, PIP1-5, MTP2-5, elbow, wrist, shoulder, knee, ankle.
#PIP 2,3; MCP 2,3; MTP 1, 2, 5, wrist, elbow, shoulder, hip, knee, ankle, talonavicular joint, subtalar joint.
@Achilles tendon, plantar fascia, quadriceps tendon insertion on patella, patellar tendon insertion on the distal pole of the patella, tibialis anterior tendon, triceps tendon, common
flexor and extensor tendons.
*Patella, patellar tendon insertion at the tibial tuberosity, Achilles tendon, plantar aponeurosis, supraspinatus tendon, biceps brachii tendon
AC, accuracy; AG, agreement; AS, axial spondylarthritis; B, binary; BE, bone erosions; CD, cartilage damage; CT, computed tomography; CTD, connective tissue disease; CTh, carti-
lage thickness; CR, conventional radiograph; EA, early arthritis; EP, enthesophyte; ERA, early rheumatoid arthritis; ESS, erosion summary score; Go, gout; HC, healthy control; HR-
pQCT, high-resolution peripheral quantitative computed tomography; MCP, metacarpophalangeal joint; MRI, magnetic resonance imaging; MTP, metatarsophalangeal joint; OA,
osteoarthritis; PIP, proximal interphalangeal joint; PsA, psoriatic arthritis; Q, quantitative; RA, rheumatoid arthritis; S, semiquantitative; STCJ, sternoclavicular joint; SZ, bone scin-
tigraphy; TMJ, temporomandibular joint; UA, undifferentiated arthritis; US, ultrasound.
Table 2
Overview of included studies and reliability, validity, feasibility or sensitivity to change.
Ref. Reliability Validity Feasibility STC
Intrarater Interrater
[59] n/a n/a SE: 85.4% n/a n/a
[34] K: 0.64 K: 0.56 n/a n/a N
[43] n/a K: 0.98 n/a n/a Y
[60] ICC: 0.93 n/a SE: 44%/ SP: 95%/ ACC:84% n/a N
[61] n/a n/a SE: 44%/ SP: 95%/ ACC:84% n/a n/a
[117] K: 0.93 n/a n/a n/a n/a
[118] n/a K: 0.4-0.99 n/a n/a n/a
[35] n/a n/a n/a n/a Y
[119] n/a K: 0.8 n/a n/a n/a
[71] n/a n/a n/a n/a N
[17] n/a K: 0.74 n/a n/a n/a
[23] n/a n/a R: 0.41-0.81 n/a n/a
[72] n/a n/a n/a n/a Y
[62] n/a n/a K: 0.55 n/a n/a
[66] n/a K: 0.68 n/a n/a n/a
[63] n/a n/a AC: 0.96/ SE:0.59/ SP: 0.98 n/a n/a
[18] n/a n/a SE: 0.79/ SP: 0.97/ AC: 0.96 n/a n/a
[33] K: 0.75 K: 0.76 n/a n/a n/a
[120] K: 0.82-0.87 n/a n/a n/a n/a
[73] n/a n/a n/a n/a Y
[64] n/a n/a K: 0.48 n/a n/a
[74] n/a n/a n/a n/a Y
[41] n/a n/a n/a n/a Y
[24] n/a K: 0.81 n/a n/a n/a
[45] n/a K: 0.81 n/a n/a n/a
[75] n/a n/a n/a n/a N
[50] ICC: 0.96 ICC: 0.97 AG: 0.93 n/a n/a
[16] n/a K: 0.72 n/a n/a n/a
[37] n/a n/a SE n/a Y
[121] n/a K: 0.64 n/a n/a n/a
[25] ICC: 0.99 n/a n/a n/a N
[76] n/a n/a n/a n/a Y
[39] n/a KW: 0.85 SE: 0.9/ SP: 0.55 n/a n/a
[30] n/a K: 0.59 SE: 0.27-1/ SP: 0.47-0.75 n/a n/a
[52] ICC: 0.13-0.86 n/a R: 0.26-0.75 n/a n/a
[32] n/a n/a n/a n/a N
[67] P>0.9 n/a SP: 0.97-1/ SE: 0.4-0.5 n/a n/a
[68] n/a n/a P: 0.68 n/a n/a
[122] ICC: 0.96/ G: 0.81 ICC: 0.97 n/a n/a n/a
[78] n/a n/a n/a n/a Y
[70] n/a n/a K: 0.01 n/a n/a
[83] n/a K: 0.69 n/a n/a n/a
[89] n/a K: BE: 0.7/ OP: 0.65 n/a n/a n/a
[65] n/a n/a K: BE: 0.86/ EP: 0.83-0.89 n/a n/a
[69] n/a K: BE: 0.65-0.89/ OP: 0.64-0.83 K: BE: 0.06/ OP: K: 0.26 n/a n/a
[85] n/a K: 0.710.88 n/a n/a n/a
[12] ICC: 0.8 ICC: 0.8 ICC: 0.61 n/a n/a
[104] n/a K: 0.36- 0.83 n/a n/a n/a
[27] n/a n/a K: 0.66-0.85 n/a n/a
[111] n/a K: BE: 0.7-1/ CD: 0.3-0.6 n/a n/a n/a
[14] AG: 0.91 AG: 0.89 AG: 0.65 n/a n/a
(continued)
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Ref. Reliability Validity Feasibility STC
[15] AG: 0.91 AG: 0.89 n/a n/a n/a
[105] n/a ICC: 0.11-1 n/a n/a n/a
[101] n/a K: BE: 0.42-0.47/ CD: 0.8 n/a n/a n/a
[77] n/a n/a n/a n/a N
[99] n/a n/a K: 0.63 n/a n/a
[103] Kr: 0.81 Kr: 0.6 Rho: 0.66 n/a n/a
[46] n/a n/a n/a n/a n/a
[123] n/a n/a n/a n/a n/a
[124] n/a n/a n/a n/a n/a
[125] n/a n/a n/a n/a n/a
[126] n/a n/a n/a n/a n/a
[127] n/a n/a n/a n/a n/a
[128] n/a n/a n/a n/a n/a
[129] n/a n/a n/a n/a n/a
[130] n/a n/a n/a n/a n/a
[131] n/a n/a n/a n/a n/a
[132] n/a n/a n/a n/a n/a
[133] n/a n/a n/a n/a n/a
[134] n/a n/a n/a n/a n/a
[135] n/a n/a n/a n/a n/a
[136] n/a n/a n/a n/a n/a
[137] n/a n/a n/a n/a n/a
[138] n/a n/a n/a n/a n/a
[139] n/a n/a n/a n/a n/a
[47] n/a n/a n/a n/a n/a
[140] n/a n/a n/a n/a n/a
[36] n/a n/a n/a n/a n/a
[141] n/a n/a n/a n/a n/a
[142] n/a n/a n/a n/a n/a
[143] n/a n/a n/a n/a n/a
[144] n/a n/a n/a n/a n/a
[53] n/a n/a n/a Y n/a
[145] n/a n/a n/a n/a n/a
[38] n/a n/a n/a n/a n/a
[28] n/a n/a n/a n/a n/a
[146] n/a n/a n/a n/a n/a
[29] n/a n/a n/a n/a n/a
[147] n/a n/a n/a n/a n/a
[148] n/a n/a n/a n/a n/a
[149] n/a n/a n/a n/a n/a
[150] n/a n/a n/a n/a n/a
[31] n/a n/a n/a n/a n/a
[151] n/a n/a n/a n/a n/a
[152] n/a n/a n/a n/a n/a
[48] n/a n/a n/a n/a n/a
[49] n/a n/a n/a n/a n/a
[40] n/a n/a n/a n/a n/a
[44] n/a n/a n/a n/a n/a
[153] n/a n/a n/a n/a n/a
[154] n/a n/a n/a n/a n/a
[155] n/a n/a n/a n/a n/a
[156] n/a n/a n/a n/a n/a
[157] n/a n/a n/a n/a n/a
[158] n/a n/a n/a n/a n/a
[159] n/a n/a n/a n/a n/a
[160] n/a n/a n/a n/a n/a
[161] n/a n/a n/a n/a n/a
[162] n/a n/a n/a n/a n/a
[163] n/a n/a n/a n/a n/a
[79] n/a n/a n/a n/a n/a
[164] n/a n/a n/a n/a n/a
[51] n/a n/a n/a n/a n/a
[165] n/a n/a n/a n/a n/a
[166] n/a n/a n/a n/a n/a
[42] n/a n/a n/a Y n/a
[167] n/a n/a n/a n/a n/a
[168] n/a n/a n/a n/a n/a
[169] n/a n/a n/a n/a n/a
[170] n/a n/a n/a n/a n/a
[171] n/a n/a n/a n/a n/a
[172] n/a n/a n/a n/a n/a
[88] n/a n/a n/a n/a n/a
[82] n/a n/a n/a n/a n/a
[84] n/a n/a n/a n/a n/a
[57] n/a n/a n/a n/a n/a
(continued)
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Ref. Reliability Validity Feasibility STC
[90]) n/a n/a n/a n/a n/a
[80] n/a n/a n/a n/a n/a
[56] n/a n/a n/a n/a n/a
[81] n/a n/a n/a n/a n/a
[91] n/a n/a n/a n/a n/a
[92] n/a n/a n/a n/a n/a
[94] n/a n/a n/a n/a n/a
[95] n/a n/a n/a n/a n/a
[96] n/a n/a n/a n/a n/a
[108] n/a n/a n/a n/a n/a
[107] n/a n/a n/a n/a n/a
[109] n/a n/a n/a n/a n/a
[26] n/a n/a n/a n/a n/a
[106] n/a n/a n/a n/a n/a
[100] n/a n/a n/a n/a n/a
[93] n/a n/a n/a n/a n/a
[87] n/a n/a n/a n/a n/a
[110] n/a n/a n/a n/a n/a
[112] n/a n/a n/a n/a n/a
[116] n/a n/a n/a n/a n/a
[113] n/a n/a n/a n/a n/a
[102] n/a n/a n/a n/a n/a
[114] n/a n/a n/a n/a n/a
AC, accuracy; AG, agreement; G, Gwet’s AC1; ICC, intraclass correlation; K, kappa; Kr, Krippendorff's alpha; KW, Kendall's W coefficient; N, no; n/a, not available; P,
Pearson’s correlation; SE, sensitivity; SP, specificity; STC, sensitivity to change; Y, yes.
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in 3/24 (12.5%) studies [87,104,105] or general irregularity of the car-
tilage in 3/24 (12.5%) studies [27,106,107]. Nine out of the 24 studies
(37.5%) only or additionally assessed cartilage thickness quantita-
tively [12,27,93,102,103,107110] (Table 1).
Joints of the hands were assessed in 15 studies [12,15,77,99-
106,111114] while 9 studies [14,26,27,87,93,107,108,110,115]
assessed other joints including the knee, shoulder, elbow and hip
joints. Cartilage damage was rated as binary (cartilage present/
absent per joint or per joint quadrant) in 12 studies
[14,15,77,99105,112,113], quantitatively by measuring cartilage
thickness in 8 studies [12,27,102,103,107110] and/or semiquanti-
tavely in 12 studies [14,15,77,99105,112,113]. Among the studies,
which utilized a semiquantitative scoring system, 2 used a damage
score combining bone erosions and cartilage loss [14,15] (Table 1).
Interobserver reliability and criterion validity expressed as
comparison with other imaging methods were analyzed in 8/24
(33.3%) [12,14,15,101,103105,111] and 5/24 (20.8%) studies
[12,15,27,99,103], respectively. Five of 8 (62.5%) studies reported
good to excellent agreement, including the two using the com-
bined bone erosions and cartilage loss score [14,15]. Agreement
was rated good to excellent in 1/2 (50%) studies using a binary
rating (range of K: 0.6-0.7), in 3/6 (50%) studies using a semi-
quantitative rating (range of ICC: 0.1-1, of K: 0.3-0.8, of AG: 89-
91%) and in 2/2 (100%) studies using a quantitative rating (ICC:
0.8, Krippendorff's alpha 0.6-0.81). Criterion validity was reported
to be good to excellent in 1/1 (100%) study using binary scoring
(K=0.7-0.9), in 3/3 (100%) studies using a semiquantitative scoring
(AG: 65%, K: 0.63, rho: 0.66) and in 1/2 (50%) study using a quan-
titative scoring (ICC: 0.6%, rho: -0.57). One (100%) study assessing
cartilage damage semiquantitatively reported no progression of
cartilage damage [77]. Condylar cartilage was found to be thicker
when measured by ultrasound as compared to MRI (2.1mm vs.
1.85mm, p<0.001) [27] (Table 2).
Malalignment and ankylosis
Only a single study assessed malalignment by ultrasound [116],
defined as the displacement of the temporomandibular joint disc
indirectly according to the anterior capsulecondyle distances. Mala-
lignment was scored in binary fashion (Table 1).One study assessed ankylosis of the sternoclavicular and the man-
ubriosternal joints [94]. Authors rated ankylosis as present or absent
(binary) without providing a definition (Table 1).
Quality assessment
All 149 studies included in the full text review underwent scoring
by QUADAS-2. In each assessed term, less than 55% revealed concerns
regarding applicability or bias among studies where the addressed
domain was applicable. The biggest risk of bias was expressed in
“flow and timing”, were 53% of the studies where this was applicable
were found to have such a risk (Fig. 2).
Discussion
One of the major advantages of ultrasound is its capability to visu-
alize and quantify synovitis, which is predictive of structural damage.
However, in contrast to the utility of ultrasound in evaluating inflam-
matory activity expressed by synovitis, much less has been published
regarding the sonographic assessment of structural damage in RA.
This SLR conducted according to the OMERACT filter 2.1, aimed to
summarize all available data specifically on this latter topic.
Most included studies assessed bone erosions. A well-conducted
systematic literature by the OMERACT Ultrasound WG published in
2016 included studies on erosions assessed by ultrasound until May
2014 [3]. Our review updates this previous study up to October 2020
and, in order to provide a more complete picture, also covers other
elementary forms of structural damage seen in RA.
Although CR is currently used to detect erosions, ultrasound was
more sensitive than CR in all studies comparing the prevalence of
erosions measured by ultrasound and CR. MRI was even more sensi-
tive than ultrasound. One possible reason for the higher sensitivity of
MRI lies in the fact that it is capable of visualizing the entire joint
while ultrasound only sees facets with an acoustic window. With the
majority of studies utilizing MRI as the reference method, ultrasound
showed a mostly good to excellent criterion validity and interob-
server agreement. Furthermore, sensitivity to change was reported in
the majority of studies suggesting ultrasound to be a sensitive out-
come measurement tool to assess changes over time. Only five stud-
ies compared bone erosions assessed by ultrasound with CT
Fig. 2. Results of the quality assessment tool for diagnostic accuracy studies (QUADAS-2) for all studies included in the systematic literature review (n=149); concerns reg applicabil-
ity: concerns regarding applicability; ref. standard: reference standard.
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standard to calculate sensitivity and specificity of ultrasound to
detect erosions. One study compared the frequency of erosions
detected by ultrasound and CT [146] and detected more erosions by
ultrasound.
Included studies which did not show changes of erosions had fol-
low-up times of 22 weeks [71], 6 months [34,75] and 12 months
[25,32,60,77] these time periods however might be too short to
detect differences.
Most radiographic scores including erosions use semiquantitative
scores [173]. While the majority of the ultrasound studies included in
this SLR scored erosions in binary fashion as present or absent on
patient or joint level or in each joint quadrant, approximately a third
of the studies used a semiquantitative scoring method. This method
was based either on the number of erosions per joint or the size of
the erosions or by a combination thereof. Counting erosions has the
disadvantage that in case two small erosions merge into one big ero-
sion, progression might be scored as improvement. In contrast, addi-
tional small erosions may not be taken into account if only the largest
erosion is counted. Thus, it seems optimal to consider both size and
number of erosions.
Cartilage damage was assessed in 19 studies. It was rated mostly
in binary fashion (cartilage damage present/ absent per joint or joint
quadrant), quantitatively by measuring cartilage damage or semi-
quantitatively. One study compared cartilage thickness measured by
ultrasound with the actual thickness subsequently measured in
cadaveric specimen. Another study measured distal femoral cartilage
thickness. Generally, intra- and interobserver reliability was moder-
ate to excellent in the included studies. Compared to measuring the
actual cartilage thickness, the binary or semiquantitative score is
independent of the patients demographic (age, gender, etc.) and
physical (height, weight, etc.) characteristics as healthy cartilage
thickness might differ from person to person based on these factors.
A recently published semiquantitative ultrasound scoring system for
cartilage damage by the OMERACT Ultrasound WG was shown to be
reliable in web-based and patient-based exercises and has already
been validated in an independent patient cohort [2,147].
Enthesophytes are typical manifestations of psoriatic arthritis and
osteoarthritis [174]. Three studies assessed enthesophytes in patients
with psoriatic arthritis and those with RA. The studies reported over-
all good interobserver agreement, although it should be pointed out
that enthesophytes were found to be quite rare in RA.
Malalignment or subluxation is widely accepted as clinical feature
of structural damage in RA and is part It is part of several radiographicdamage scores [175,176]. However, only one included study assessed
malalignment by ultrasound, highlighting a need for future studies in
this area.
Although theoretically all synovial joints can be affected in RA,
screening all joints by ultrasound for damage is not feasible. The
detection of damage is important for diagnosis, evaluation of therapy
as well as for its predictive value. Target joints for assessment of
structural damage should be those that are affected often and early in
the course of the disease. Small joints of the hands and feet are
affected in the majority of patients with RA and studies showed that
they are predictive of composite scores including both small and
large joints. Furthermore, MTP joints have been shown to be the site
where erosions initially develop [177]. Thus, most CR- based damage
scores include hands and feet [173,175177]. Similarly, most
included ultrasound studies assessed joints of the hand and/or MTPs.
Only few studies included large joints, which limits the generalizabil-
ity of this review to all joints. The assessment of small joints of the
hands and feet however seems feasible and practical considering
they are early and frequent locations for structural damage. RA is a
symmetrical disease. All but 22 studies assessed joints bilaterally. In
several studies, more erosions with faster progression were found on
the dominant hand compared to the non-dominant hand [178,179].
In contrast, synovitis is not thought to develop more often on the
dominant hand [180]. Whether assessing structural joint damage by
ultrasound on one side only is sufficient, will have to be addressed in
future studies. In order to correctly interpret structural damage
assessed by ultrasound, the recognition of the frequency and charac-
teristics of these features in healthy individuals is important. Due to
the fact that ultrasound seems to be more sensitive than CR, sono-
graphically detected damage should be interpreted with particular
caution. Several studies found ultrasound signs of synovitis as well as
structural damage in healthy individuals [181183].
While this review aims to cover the elementary forms of struc-
tural damage seen in RA, damage to periarticular and articular soft
tissues, such as ligaments, tendons and muscles were not included,
which is a limitation. We also did not include joint space narrowing,
since this mainly corresponds to cartilage loss and also because ultra-
sound is not considered to be an ideal modality for its assessment.
In conclusion, the findings of this systemic literature review sug-
gest that ultrasound is a valid and reliable outcome measurement
tool to detect joint damage, particularly in small joints of the hands
and feet where validated definitions and scoring system exist. Ero-
sions and cartilage damage were the most often assessed and most
prevalent features. The development of a composite or combined
636 I. Gessl et al. / Seminars in Arthritis and Rheumatism 51 (2021) 627639ultrasound damage score and the determination of target joints are
tasks for future studies. These should ideally consist of consensus def-
initions and scanning characteristics of elementary lesions of struc-
tural damage, the scoring thereof, followed by validation of such
lesions and scoring systems, first in web-based and patient-based
exercises, and finally in clinical studies.
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